Sanofi
SNYNF
$84.97
-$1.67-1.93%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 28.48% | 12.70% | 7.38% | 79.07% | |
| Total Other Revenue | 25.90% | 7.15% | -13.09% | -34.18% | |
| Total Revenue | 28.28% | 12.30% | 5.71% | 58.53% | |
| Cost of Revenue | 21.44% | 6.42% | -5.67% | 39.38% | |
| Gross Profit | 31.42% | 14.75% | 10.71% | 69.18% | |
| SG&A Expenses | 22.79% | 10.60% | 2.04% | 114.63% | |
| Depreciation & Amortization | 43.55% | -2.75% | -20.09% | 36.71% | |
| Other Operating Expenses | 99.96% | 50.84% | 44.61% | -56.57% | |
| Total Operating Expenses | 28.05% | 15.57% | 2.34% | 29.05% | |
| Operating Income | 29.70% | -2.26% | 20.95% | 504.89% | |
| Income Before Tax | -295.79% | 15.64% | 95.12% | 150.94% | |
| Income Tax Expenses | -452.92% | -11.52% | 348.34% | 136.74% | |
| Earnings from Continuing Operations | -264.26% | 22.65% | 68.49% | 155.23% | |
| Earnings from Discontinued Operations | 107.65% | 6,439.06% | 7.43% | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 27.60% | -8.47% | -56.59% | -404.88% | |
| Net Income | -356.99% | 276.56% | 60.17% | 154.31% | |
| EBIT | 29.70% | -2.26% | 20.95% | 504.89% | |
| EBITDA | 30.47% | -0.94% | -2.19% | 852.14% | |
| EPS Basic | -367.82% | 286.74% | 62.11% | 153.50% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -369.88% | 289.65% | 62.11% | 153.09% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -3.09% | -2.59% | -1.19% | -0.02% | |
| Average Diluted Shares Outstanding | -3.46% | -2.93% | -1.19% | -0.02% | |
| Dividend Per Share | 14.78% | -- | -- | 3.23% | |
| Payout Ratio | -8.04% | -0.42% | -- | 0.03% | |